Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Promising new cocktail for bile duct cancer shows early hope

NCT ID NCT07392541

Recruiting now Disease control Sponsor: Tongji Hospital Source: ClinicalTrials.gov ↗

First seen Feb 06, 2026 · Last updated May 22, 2026 · Updated 18 times

Summary

This study tests a new combination of four drugs for people with advanced bile duct cancer that cannot be removed by surgery. The treatment adds an immunotherapy drug (adebrelimab) and a common cholesterol-lowering drug (simvastatin) to standard chemotherapy. The goal is to see if this mix can shrink tumors and keep the cancer from growing longer than standard treatment alone. About 29 participants will receive the same combination, and researchers will closely monitor safety and effectiveness.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED BILIARY TRACT CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Tongji Hospital

    RECRUITING

    Wuhan, Hubei, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

ADVANCED BILIARY TRACT CARCINOMA